Washington Trust Bank’s iShares Biotechnology ETF IBB Stock Holding History

Washington Trust Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-300	Closed	-$26K	–	1136
2016 Q2	$26K	Buy	+300	New	+$26.9K	0.01%	458

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Washington Trust Bank's IBB Position: Q3 2016 in Review

Washington Trust Bank sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 300 shares — an estimated $26K sold.

Washington Trust Bank first reported a position in IBB in Q2 2016 and held it in 1 quarter. The position peaked at $26K in Q2 2016. 463 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

Washington Trust Bank reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
Washington Trust Bank sold 300 iShares Biotechnology ETF shares in Q3 2016, an estimated $26K.
Washington Trust Bank first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 1 quarter.
Washington Trust Bank's iShares Biotechnology ETF position peaked at $26K in Q2 2016.
463 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Washington Trust Bank's 13F filing for Q3 2016, filed 4 Oct 2016.